Episona Gets $4M For Male Infertility Testing
socalTECH
JUNE 14, 2017
According to Episona, the funding came from the Pasadena Angeles, as well as other high-net worth individuals from Pasadena and San Francisco. Episona has been offering up its test since October of 2016. Episona develops an epigenetic test which examines DNA for risk factors related to male factor fertility and poor embryo quality.
Let's personalize your content